Access cutting-edge facioscapulohumeral muscular dystrophy treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access facioscapulohumeral muscular dystrophy specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related facioscapulohumeral muscular dystrophy treatment provided free
The goal of this clinical trial is to learn how safe and tolerable EPI-321 is and whether there may be early signs it is working in male or female adult (18 to 75 years) participants with facioscapulohumeral muscular dystrophy (FSHD) Type 1 condition. The main questions it aims to answer are: How safe is EPI-321 and how well can people handle it over time? How does EPI-321 interact with its target and does it show early signs of working? Participants will receive a single dose of EPI-321 throu
Sponsor: Epicrispr Biotechnologies, Inc.
Check if you qualify for this facioscapulohumeral muscular dystrophy clinical trial in Atlanta, GA
If you're searching for facioscapulohumeral muscular dystrophy treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced facioscapulohumeral muscular dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.